Resistin Promotes Endothelial Cell Activation

Resistin
DOI: 10.1161/01.cir.0000084503.91330.49 Publication Date: 2003-07-22T00:34:50Z
ABSTRACT
Adipocyte-derived hormones may represent a mechanism linking insulin resistance to cardiovascular disease. In the present study, we evaluated direct effects of resistin, novel adipocyte-derived hormone, on endothelial activation.Endothelial cells (ECs) were incubated with human recombinant resistin (10 100 ng/ML, 24 hours), and endothelin-1 (ET-1) release, ET-1 mRNA expression, nitric oxide (NO) production assessed. Transient transfection assays used evaluate transcription gene promoter. Furthermore, AP-1-mutated promoter evaluated. The expression vascular cell adhesion molecule (VCAM-1) monocyte chemoattractant chemokine (MCP-1) studied in addition CD40 receptor, ligand-induced MCP-1 tumor necrosis factor receptor-associated factor-3 (TRAF3), an inhibitor signaling. Incubation ECs resulted increase release no change NO production. Whereas treatment activity, was inactive after stimulation. Additionally, resistin-treated showed increased VCAM-1 MCP-1, concomitant reductions TRAF-3 expression. Resistin did not alter receptor expression; however, ligand induced production.The adipokine exerts promote EC activation by promoting part inducing activity via AP-1 site. upregulates molecules chemokines downregulates TRAF-3, this fashion, be mechanistically linked disease metabolic syndrome.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (21)
CITATIONS (513)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....